Position in ADMA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$11,019,674
-$5,465,652 QoQ
Shares Held
1,316,568
-28.0% QoQ
Ownership
0.588%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#33
of 323 holders
Holding Since
Jun 2020
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ADMA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Qube Research & Technologies Ltd holds $2,443,042,063 across 169 Biotechnology names. ADMA ranks #41 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
798,715 | $240,437,176 | |
| 2 | INSM |
INSMED Inc
|
1,682,334 | $179,370,451 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
221,607 | $138,180,828 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
3,454,496 | $122,254,613 | |
| 5 | AXSM |
Axsome Therapeutics, Inc.
|
426,336 | $104,354,262 | |
| 6 | APGE |
Apogee Therapeutics, Inc.
|
659,678 | $87,559,060 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
1,443,230 | $81,989,896 | |
| 8 | RPRX |
Royalty Pharma plc
|
1,412,112 | $79,177,119 |
All Filings in ADMA
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,019,674 | 1,316,568 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $16,485,326 | 1,829,670 | Shares | Sole | 2026-05-15 | |
| 2025-09-30 | $2,406,072 | 164,125 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $5,266,058 | 289,185 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $4,910,122 | 247,486 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $10,337,454 | 602,767 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $6,158,559 | 308,082 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $4,655,586 | 416,421 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $1,243,070 | 188,344 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $3,487,048 | 771,471 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $4,312,639 | 1,204,648 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $3,616,022 | 979,952 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $1,772,495 | 535,497 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $163,243 | 42,073 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $711,900 | 292,963 | Shares | Sole | 2022-11-14 | |
| 2022-03-31 | $270,986 | 148,080 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $147,429 | 104,560 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $13,319 | 11,787 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $212,139 | 132,587 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $63,694 | 36,190 | Shares | Sole | 2021-05-14 | |
| 2020-06-30 | $104,217 | 35,569 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||